32 bp CCR-5 gene deletion and resistance to fast progression in HIV-1 infected heterozygotes.

作者信息

Rappaport J, Cho Y Y, Hendel H, Schwartz E J, Schachter F, Zagury J F

出版信息

Lancet. 1997 Mar 29;349(9056):922-3. doi: 10.1016/S0140-6736(05)62697-9.

DOI:10.1016/S0140-6736(05)62697-9

PMID:9093257

Abstract

摘要

相似文献

32 bp CCR-5 gene deletion and resistance to fast progression in HIV-1 infected heterozygotes.

Lancet. 1997 Mar 29;349(9056):922-3. doi: 10.1016/S0140-6736(05)62697-9.

HIV-1 infection in an individual homozygous for the CCR5 deletion allele.

Nat Med. 1997 Mar;3(3):252-3. doi: 10.1038/nm0397-252.

Resistance to HIV-1 infection: it's in the genes.

Nat Med. 1996 Sep;2(9):966-7. doi: 10.1038/nm0996-966.

CCR5-delta 32 gene deletion in HIV-1 infected patients.

Lancet. 1997 Sep 6;350(9079):742. doi: 10.1016/S0140-6736(05)63554-4.

CCR5-delta 32 gene deletion in HIV-1 infected patients.

Lancet. 1997 Sep 6;350(9079):741-2. doi: 10.1016/S0140-6736(05)63552-0.

CCR5-delta 32 gene deletion in HIV-1 infected patients.

Lancet. 1997 Sep 6;350(9079):741; author reply 742. doi: 10.1016/S0140-6736(05)63551-9.

HIV-1 infection in an individual homozygous for CCR5 delta 32. Seroco Study Group.

Lancet. 1997 Apr 26;349(9060):1219-20.

Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group.

AIDS. 1997 Sep;11(11):F73-8. doi: 10.1097/00002030-199711000-00001.

The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.

Nat Med. 1996 Nov;2(11):1240-3. doi: 10.1038/nm1196-1240.

Dual effect of CCR5 delta 32 gene deletion in HIV-1-infected patients. Copenhagen AIDS Study Group.

Lancet. 1997 Jun 28;349(9069):1884. doi: 10.1016/s0140-6736(05)63874-3.

引用本文的文献

A cohort-based study of host gene expression: tumor suppressor and innate immune/inflammatory pathways associated with the HIV reservoir size.

PLoS Pathog. 2023 Nov 29;19(11):e1011114. doi: 10.1371/journal.ppat.1011114. eCollection 2023 Nov.

Large-Scale "OMICS" Studies to Explore the Physiopatholgy of HIV-1 Infection.

Front Genet. 2019 Sep 13;10:799. doi: 10.3389/fgene.2019.00799. eCollection 2019.

Transcriptional down-regulation of in a subset of HIV+ controllers and their family members.

Elife. 2019 Apr 9;8:e44360. doi: 10.7554/eLife.44360.

Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers.

Yale J Biol Med. 2017 Jun 23;90(2):245-259. eCollection 2017 Jun.

Identification of Genes Whose Expression Profile Is Associated with Non-Progression towards AIDS Using eQTLs.

PLoS One. 2015 Sep 14;10(9):e0136989. doi: 10.1371/journal.pone.0136989. eCollection 2015.

A systematic review of definitions of extreme phenotypes of HIV control and progression.

AIDS. 2014 Jan 14;28(2):149-62. doi: 10.1097/QAD.0000000000000049.

Genome-wide association studies on HIV susceptibility, pathogenesis and pharmacogenomics.

Retrovirology. 2012 Aug 24;9:70. doi: 10.1186/1742-4690-9-70.

Stem cell-based anti-HIV gene therapy.

Virology. 2011 Mar 15;411(2):260-72. doi: 10.1016/j.virol.2010.12.039. Epub 2011 Jan 17.

Screening low-frequency SNPS from genome-wide association study reveals a new risk allele for progression to AIDS.

J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):279-84. doi: 10.1097/QAI.0b013e318204982b.

Multiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to AIDS.

J Infect Dis. 2010 Sep 15;202(6):908-15. doi: 10.1086/655782.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验